Drug Co. Lied About $245M Buyout Offer, SEC Claims
The U.S. Securities and Exchange Commission hit Spencer Pharmaceutical Inc. with a suit in Massachusetts federal court Monday, accusing the drug company of a pump-and-dump scheme in which Spencer's officers spread...To view the full article, register now.
Already a subscriber? Click here to view full article